News – Page 4 of 13

Quantum Dice raises £2 million in pre-seed funding to revolutionise the security of encryption keys

12th October 2021

Oxford University Spinout, Quantum Dice, announces the completion of its pre-seed fundraise, where a £1 million venture capital consortium was led by the notable venture capital fund…

Supporting the leaders of tomorrow’s scale ups with Horizon 37

21st September 2021

UKI2S is proud to invest in innovative early-stage companies, helping them to commercialise their research.

CEO Spotlight: Neil Martin, CEO Vector Photonics

6th September 2021

Vector Photonics is a spin-out from the University of Glasgow, based on world-leading semiconductor research led by Professor Richard Hogg.

Presymptom Health Receives Additional Funding to Support its Trials of an Early Test for Sepsis

25th August 2021

Medical technology company Presymptom Health has successfully closed its seed round funding to support the development of its pioneering blood test for the early detection of sepsis.

Cell and Gene Therapy: challenges, developments and exciting possibilities

17th August 2021

Drug discovery and development has never been more of a focus, for the public, researchers and investors. Cell and gene therapies are often regarded as a silver bullet of the future, but what challenges stand in the way?

Andrew Mackintosh appointed as new Chair of UK Innovation and Science Seed Fund Advisory Board

19th July 2021

The UK Innovation and Science Seed Fund (UKI2S) is pleased to announce the appointment of Dr Andrew Mackintosh as the new Chair of its Advisory Board.

NanoSyrinx raises £6.2m to develop its engineering biology platform for targeted intracellular engineering

19th July 2021

NanoSyrinx, a biotech company developing a new cell engineering tool for novel targeted therapeutic modalities, has raised a further £6.2m of seed financing…

CEO Spotlight: Jonathan Wogel, Executive Chairman, Zentraxa

8th July 2021

Jonathan Wogel, Executive Chairman of UKI2S portfolio company Zentraxa, has a career of two halves, starting his journey in large, international corporations…

Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s disease

23rd June 2021

Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy…

Funding boost supports growing high-tech companies in the UK

21st June 2021

UKRI has provided a £10million funding boost to the UK Innovation and Science Seed Fund (UKI2S), supporting early-stage businesses arising from world-class…

Minister for Science Opens New High-Tech Divertor Lab at Tokamak Energy

17th June 2021

Tokamak Energy’s new high tech divertor lab has been opened today by Minister for Science, Research and Innovation Amanda Solloway MP.

Cross-cultural collaboration: learning from each other

8th June 2021

Against the challenging backdrop of a global pandemic, 2020 saw the successful merger of UKI2S portfolio company Perfectus Biomed and US-based Extherid Biosciences.

Patenting Innovation: Intellectual property in gene editing

24th May 2021

2021 is set to be an interesting year for gene editing. Gene therapy research is in its adolescence, and the ups and downs are played out almost every day…

The Electrospinning Company raises £4.5m ($6.3m) with participation from new strategic investor

5th May 2021

The Electrospinning Company (Electrospinning), a leader in the development and manufacture of nanofibrous biomaterials for use in tissue regenerative devices, has completed a £4.5m ($6.3m) fundraising round.

Harwell-based Helix Technologies completes funding round led by Midven-managed UK Innovation & Science Seed Fund

21st April 2021

Helix Technologies, developer of resilient, precision antennas for GNSS (Global Navigation Satellite Systems), is pleased to announce it has completed a significant investment.

Vector Photonics’ £1.6m equity investment for next generation laser commercialisation takes its seed funding round to £4m

14th April 2021

Vector Photonics has received £1.6m of equity investment to commercialise its unique, PCSEL-based, semiconductor laser technology.

Future Planet Capital acquires Midven Ltd, one of the UK’s oldest venture capital firms

8th April 2021

Future Planet Capital (FPC) has announced its acquisition of one of Britain’s most respected venture capital firms, Midven Ltd.

Supporting fusion energy development in the UK

30th March 2021

The UK is at the forefront of fusion energy research and development, hosting the EU’s Joint European Torus (JET), the world’s leading fusion machine, as well as a growing ecosystem of public and privately funded initiatives.

CEO Spotlight: Laura Knight, COO, The Smarter Food Company

22nd March 2021

Our ‘CEO Spotlight’ series seeks to recognise the wide range of diverse innovators we work with and support. In the most recent instalment, we hear from…

Cytoseek raises £3.57m ($5m) to advance its mission to develop the next generation of cell therapies for cancer

19th March 2021

A discovery-stage biotech company developing the next generation of cell therapies to treat cancer, is excited to announce today the completion of a £3.57M ($5M) funding round.

Experienced CRO and Biotech executive, Dr Lloyd Payne, joins Perfectus Biomed Group as non-executive director

16th March 2021

Perfectus Biomed is delighted to announce the appointment of Dr Lloyd Payne to the role of non-executive director.

Advanced Materials in the UK: Investment opportunities

2nd March 2021

The UK materials manufacturing sector turns over £33.5bn per year, comparable to the aerospace sector at £31.1bn[1].

Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease

28th February 2021

Non-invasive genetic test enables physicians to assess an individual’s risk of cognitive decline due to Alzheimer’s from a simple saliva sample provided from home.

University of Birmingham spin-out secures £800k for point of care diagnostics platform

24th February 2021

The second round of funding will enable the company to commence the development of the hardware platform for its tests.

Latest Insights, Interviews, News, and Resources.

Quantum Dice raises £2 million in pre-seed funding to revolutionise the security of encryption keys

Supporting the leaders of tomorrow’s scale ups with Horizon 37

CEO Spotlight: Neil Martin, CEO Vector Photonics

Presymptom Health Receives Additional Funding to Support its Trials of an Early Test for Sepsis

Cell and Gene Therapy: challenges, developments and exciting possibilities

Andrew Mackintosh appointed as new Chair of UK Innovation and Science Seed Fund Advisory Board

NanoSyrinx raises £6.2m to develop its engineering biology platform for targeted intracellular engineering

CEO Spotlight: Jonathan Wogel, Executive Chairman, Zentraxa

Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s disease

Funding boost supports growing high-tech companies in the UK

Minister for Science Opens New High-Tech Divertor Lab at Tokamak Energy

Cross-cultural collaboration: learning from each other

Patenting Innovation: Intellectual property in gene editing

The Electrospinning Company raises £4.5m ($6.3m) with participation from new strategic investor

Harwell-based Helix Technologies completes funding round led by Midven-managed UK Innovation & Science Seed Fund

Vector Photonics’ £1.6m equity investment for next generation laser commercialisation takes its seed funding round to £4m

Future Planet Capital acquires Midven Ltd, one of the UK’s oldest venture capital firms

Supporting fusion energy development in the UK

CEO Spotlight: Laura Knight, COO, The Smarter Food Company

Cytoseek raises £3.57m ($5m) to advance its mission to develop the next generation of cell therapies for cancer

Experienced CRO and Biotech executive, Dr Lloyd Payne, joins Perfectus Biomed Group as non-executive director

Advanced Materials in the UK: Investment opportunities

Cytox launches genoSCORE-LAB test to predict the risk of developing Alzheimer’s disease

University of Birmingham spin-out secures £800k for point of care diagnostics platform

Stay updated